Development of a novel biologic to treat preeclampsia
Ended Project Grant Awarded Last action
- Award ID
- R44HD082657
- Recipient
-
Aggamin Pharmaceuticals LLC UEI E21PRNABGN38
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,361,855
Award facts
- Assistance listing
- 93.865 Child Health and Human Development Extramural Research
- Completion date
- Originally
- Place of performance
- New York, NY 10032, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $511,969 | |
| Original award | $849,886 |
Quick answers
Who received award R44HD082657?
R44HD082657 was awarded to Aggamin Pharmaceuticals LLC by National Institute of Child Health and Human Development (National Institutes of Health) on September 25, 2014.
How much is award R44HD082657 worth?
$1,361,855 has been obligated on R44HD082657.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award